Categories AlphaGraphs, Earnings, Health Care
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today.
Total revenue increased 3% year-over-year to $2.5 billion.
Net income attributable to Biogen Inc. was $266.8 million, or $1.83 per share, compared to $249.7 million, or $1.71 per share, last year. Adjusted EPS grew 17% YoY to $3.44.
For full-year 2025, the company expects total revenue to decline by a mid-single digit percentage at constant currency versus full-year 2024. Adjusted EPS is expected to be $15.25-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How UnitedHealth Group (UNH) performed in Q1 2025
UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8 billion in the same quarter a year ago. Net earnings
INFY Earnings: Infosys Q4 profit drops despite an increase in revenues
Infosys (NYSE: INFY) Thursday reported an increase in revenues for the fourth quarter of 2025. However, Q4 profit declined year-over-year. The software firm’s revenues increased 3.6% year-over-year to $4.73 billion
AXP Earnings: Key quarterly highlights from American Express’ Q1 2025 financial results
American Express Company (NYSE: AXP) reported its first quarter 2025 earnings results today. Consolidated total revenues net of interest expense were $17 billion, up 7% year-over-year. Revenues grew 8% on
